ZLD10A is a highly potent and selective small molecule inhibitor of EZH2. EZH2 overexpression is implicated in tumorigenesis and has been a candidate oncogene in several tumor types. References: Song X, Zhang L, Gao T, Ye T, Zhu Y, Lei Q, Feng Q, He B, Deng H, Yu L. Selective inhibition of EZH2 by ZLD10A blocks H3K27 methylation and kills mutant lymphoma cells proliferation. Biomed Pharmacother. 2016 Jul;8288-94. doi: 10.1016/j.biopha.2016.04.019. Epub 2016 Apr 25. PubMed PMID: 27261606.

纯度：≥98%

CAS：1782064-91-8